Becton Dickinson (BDX) Cash & Equivalents (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Cash & Equivalents of $813.0 million for Q1 2026, up 21.89% year-over-year from $667.0 million in Q1 2025, and up 9.86% quarter-over-quarter from $740.0 million in Q4 2025.
Becton Dickinson (BDX) Cash & Equivalents (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Cash & Equivalents for 18 consecutive years, with $813.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents rose 21.89% year-over-year to $813.0 million; the TTM figure through Mar 2026 stood at $813.0 million (up 21.89% YoY), while the FY2025 annual figure was $567.0 million, down 66.98% from the prior year.
- Cash & Equivalents advanced to $813.0 million in Q1 2026 per BDX's latest filing, from $740.0 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $4.5 billion in Q2 2024 and bottomed at $567.0 million in Q3 2025.
- Historically, Cash & Equivalents has averaged $1.5 billion across 5 years, with a median of $1.0 billion in 2022.
- Annual changes were most pronounced in 2024 — Cash & Equivalents jumped 383.1% — and 2025, when it tumbled 83.52%.
- Becton Dickinson's Cash & Equivalents stood at $612.0 million in 2022, then jumped by 92.81% to $1.2 billion in 2023, then plunged by 39.75% to $711.0 million in 2024, then increased by 4.08% to $740.0 million in 2025, then climbed by 9.86% to $813.0 million in 2026.
- Business Quant data shows BDX's Cash & Equivalents at $813.0 million in Q1 2026, $740.0 million in Q4 2025, and $567.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 2.76 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 708.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.33 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 1.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 708.00 Mn |
| Mar 31, 2026 | 813.00 Mn |
| Dec 31, 2025 | 740.00 Mn |
| Sep 30, 2025 | 567.00 Mn |
| Jun 30, 2025 | 735.00 Mn |
| Mar 31, 2025 | 667.00 Mn |
| Dec 31, 2024 | 711.00 Mn |
| Sep 30, 2024 | 1.72 Bn |
| Jun 30, 2024 | 4.46 Bn |
| Mar 31, 2024 | 2.35 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.42 Bn |
| Jun 30, 2023 | 923.00 Mn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | 612.00 Mn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 2.56 Bn |
| Mar 31, 2022 | 3.15 Bn |
| Dec 31, 2021 | 1.90 Bn |
| Sep 30, 2021 | 2.28 Bn |